Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [ACTIVE] · [HEALTH]

2 clusters · 5 sources · 11 days · First seen 12 days ago · Last updated 1 day ago

Hepatitis B research and treatment development

Overview

Efforts to develop treatments and a cure for hepatitis B have emerged through both large-scale international research and specific technological developments.

A global research consortium led by Johns Hopkins University has launched a five-year study involving researchers from the United States, Brazil, India, Senegal, and Uganda. The initiative aims to monitor 600 patients to observe viral behavior and immune responses, with the long-term goal of eliminating hepatitis B as a public health problem by 2030.

In a separate development, Sechenov University and R-Pharm have begun developing a gene-editing treatment using CRISPR-Cas9 technology. Supported by the Academician E.P. Velikhov grant, this approach utilizes biocompatible nanoparticles to target viral DNA in liver cells. The goal of this method is to achieve a complete cure via a single injection while minimizing risks to the human genome.

Entities

Johns Hopkins University · University of São Paulo · Tânia Reuter · Sechenov University · R-Pharm

Timeline

1 day ago

[HEALTH] 2 sources
Sechenov University begins Hepatitis B gene-editing drug development
Sechenov University and R-Pharm are developing a CRISPR-Cas9 based treatment for Hepatitis B that aims to cure the virus with a single injection using nanoparticle delivery.
12 days ago

[HEALTH] 3 sources
Global research consortium seeks hepatitis B cure
A global research consortium led by Johns Hopkins University is studying hepatitis B and HIV co-infection to find new treatments and a potential cure, involving researchers from Brazil, India, Senegal, and ug.

Sources

alnilin.com · elbalad.news · maringamais.com.br · oimparcial.com.br · soundtrack.fm